Related Experiment Videos
Physiological regulation of NEFA availability: lipolysis pathway
1Franco-Czech Laboratory for Clinical Research of Obesity, Third Faculty of Medicine, Charles University, Prague, Czech Republic. vladimir.stich@lf3.cuni.cz
The Proceedings of the Nutrition Society
|August 6, 2004
Summary
Plasma non-esterified fatty acids (NEFA) are vital energy sources but contribute to insulin resistance. Their mobilization from fat tissue via lipolysis is hormonally controlled, influenced by diet and exercise.
Area of Science:
- Metabolic Physiology
- Endocrinology
- Lipid Metabolism
Background:
- Plasma non-esterified fatty acids (NEFA) serve as crucial energy substrates.
- NEFA availability is primarily regulated by lipolysis in adipose tissue.
- Lipolysis is modulated by hormonal, paracrine, and autocrine signals, including catecholamines, insulin, and adipocytokines.
Purpose of the Study:
- To explore the hormonal regulation of adipose tissue lipolysis.
- To investigate how physiological states like diet and exercise affect NEFA mobilization.
- To examine if long-term interventions can correct dysregulated lipolysis in obesity and diabetes.
Main Methods:
- Review of hormonal and paracrine/autocrine signaling pathways governing lipolysis.
- Analysis of NEFA mobilization patterns in different physiological states (post-absorptive, postprandial, exercise).
- Consideration of long-term effects of energy balance interventions (diet, exercise) and pathological states (obesity, diabetes).
Main Results:
- Hormonal signals dynamically regulate NEFA mobilization, increasing it during fasting and exercise, and decreasing it after meals.
- Diet and physical activity are key physiological variables influencing hormonal signaling in lipolysis.
- Lipolysis regulation is altered in obesity and diabetes.
Conclusions:
- Hormonal regulation of NEFA mobilization is adaptable to physiological demands.
- Long-term interventions like diet and exercise may offer therapeutic potential for metabolic disturbances.
- Further research is needed to confirm if these interventions can 'correct' lipolysis dysregulation in obese and diabetic individuals.